scispace - formally typeset
S

Severin P. Schwarzacher

Researcher at University of Innsbruck

Publications -  58
Citations -  2681

Severin P. Schwarzacher is an academic researcher from University of Innsbruck. The author has contributed to research in topics: Intravascular ultrasound & Vascular endothelial growth factor. The author has an hindex of 26, co-authored 57 publications receiving 2637 citations. Previous affiliations of Severin P. Schwarzacher include University of Vienna & Stanford University.

Papers
More filters
Journal ArticleDOI

Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.

TL;DR: The present findings suggest that the impairment of FMD in the brachial artery, a marker of systemic endothelial function, is closely related to the angiographic extent of CAD.
Journal ArticleDOI

HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

TL;DR: Findings support the concept that statins have antiinflammatory and antiproliferative effects that are relevant in the treatment of atherosclerotic diseases.
Journal ArticleDOI

Predictors and outcomes of stent thrombosis. An intravascular ultrasound registry

TL;DR: On comparison with angiography, the vast majority of stents associated with subsequent thrombosis have at least one abnormal feature by intravascular ultrasound at the time of stent deployment.
Journal ArticleDOI

Regression of atherosclerosis: role of nitric oxide and apoptosis.

TL;DR: Results indicate that supplemental L-arginine induces apoptosis of macrophages in intimal lesions by its metabolism to NO, which acts through a cGMP-independent pathway, consistent with previous observation that supplementation of dietary arginine induces regression of atheroma in this animal model.
Journal ArticleDOI

Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise.

TL;DR: In this article, biochemical evidence was provided that ultra-endurance exercise may cause subclinical myocardial damage, even in well-trained cyclists, and the cellular nature of this damage and its clinical relevance remain unknown at present.